Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Aug 2026 for Cue Biopharma, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Pamela Garzone: trading record in brief
This profile gathers the share dealings of Pamela Garzone in Cue Biopharma, Inc. We count 2 filings, every one of them for a trade on 9 July 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 28 August 2026, the filings show a share grant in Cue Biopharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Pamela Garzone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
18,900 shares0Common StockSEC:0001974756-26-000006:0
21,800 shares0Common StockSEC:0001974756-26-000004:0
2 of 2 declarations
